931 Results

People

  1. Brennan
    Brennan
  2. Vickers
    Vickers
  3. Reuter
    Reuter
  4. Barakat
    Barakat
  5. Soslow
    Soslow
  6. Cordon-Cardo
    Cordon-Cardo
  7. Antonescu
    Antonescu
  8. Herr
    Herr
  9. Alektiar
    Alektiar
  10. Eastham
    Eastham

Groups

  1. Surgery (427)
  2. Department of Pathology and Laboratory Medicine (220)
  3. Department of Medicine (216)
  4. Solid Tumor Oncology Division (172)
  5. Epidemiology and Biostatistics (158)
  6. Urology (134)
  7. Sloan Kettering Institute Faculty (133)
  8. Survivorship Research (128)
  9. GSK Faculty (119)
  10. Molecular Pharmacology and Chemistry Program Faculty (118)
  1. "cancer grading"
Formats
  1. Journal Article (874)
  2. Review (20)
  3. Conference Paper (14)
  4. Editorial (12)
  5. Research Letter (4)
  6. Correspondence (3)
  7. Guidelines (3)
  8. Miscellaneous (1)
Groups
  1. Surgery (427)
  2. Department of Pathology and Laboratory Medicine (220)
  3. Department of Medicine (216)
  4. Solid Tumor Oncology Division (172)
  5. Epidemiology and Biostatistics (158)
  6. Urology (134)

More Groups

People
  1. Murray Brennan (57)
  2. Andrew Vickers (44)
  3. Robert Soslow (44)
  4. Victor Reuter (43)
  5. Peter Scardino (41)
  6. Richard Barakat (37)

More People

Years
  1. 2025 (22)
  2. 2024 (58)
  3. 2023 (31)
  4. 2022 (30)
  5. 2021 (13)
  6. 2020 (44)

More Years

Publications
  1. Cancer (59)
  2. Gynecologic Oncology (42)
  3. American Journal of Surgical Pathology (38)
  4. Annals of Surgical Oncology (35)
  5. Journal of Urology (34)
  6. Journal of Clinical Oncology (33)

More Publications

Publishers
  1. Elsevier Inc. (139)
  2. Elsevier Science, Inc. (103)
  3. Wiley Blackwell (99)
  4. Springer (93)
  5. Lippincott Williams & Wilkins (90)
  6. American Association for Cancer Research (38)

More Publishers

Results (931)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Managing potential adverse events during treatment with enfortumab vedotin + pembrolizumab in patients with advanced urothelial cancer
    Review

    Brower, B.; McCoy, A.; Ahmad, H.; Eitman, C.; Bowman, I. A.; Rembisz, J.; Milowsky, M. I.
    Frontiers in Oncology (2024)

    Fulltext@MSK | Save
  • Characterization of natural killer and cytotoxic T-cell immune infiltrates in pancreatic ductal adenocarcinoma
    Journal Article

    Persky, J.; Cruz, S. M.; Darrow, M. A.; Judge, S. J.; Li, Y.; Bold, R. J.; Karnezis, A. N.; Matsukuma, K. E.; Qi, L.; Canter, R. J.
    Journal of Surgical Oncology (2024)

    Fulltext@MSK | Save
  • Skeletal muscle and visceral adipose radiodensities are pre-surgical, non-invasive markers of aggressive kidney cancer
    Journal Article

    Furberg, H.; Bradshaw, P. T.; Knezevic, A.; Olsson, L.; Petruzella, S.; Stein, E.; Paris, M.; Scott, J.; Akin, O.; Hakimi, A. A.; more...
    Journal of Cachexia, Sarcopenia and Muscle (2024)

    Fulltext@MSK | Save
  • Response to 2 induction courses of bacillus Calmette-Guèrin therapy among patients with high-risk non-muscle-invasive bladder cancer: 5-year follow-up of a phase 2 clinical trial
    Journal Article

    Katims, A. B.; Tallman, J.; Vertosick, E.; Porwal, S.; Dalbagni, G.; Cha, E. K.; Smith, R.; Benfante, N.; Herr, H. W.
    JAMA Oncology (2024)

    Fulltext@MSK | Save
  • Pilot study: A simple CAD-based tool to detect breast cancer on MRI of the breast
    Journal Article

    Bennani-Baiti, B. I.; Weber, M.; Bernathova, M.; Clauser, P.; Kapetas, P.; Pinker, K.; Woitek, R.; Helbich, T.; Baltzer, P. T. A.
    Magnetic Resonance Imaging (2024)

    Fulltext@MSK | Save
  • L1 cell adhesion molecule (L1CAM) expression and molecular alterations distinguish low-grade oncocytic tumor from eosinophilic chromophobe renal cell carcinoma
    Journal Article

    Alghamdi, M.; Chen, J. F.; Jungbluth, A.; Koutzaki, S.; Palmer, M. B.; Al-Ahmadie, H. A.; Fine, S. W.; Gopalan, A.; Sarungbam, J.; Sirintrapun, S. J.; more...
    Modern Pathology (2024)

    Fulltext@MSK | Save
  • Cholecystectomy at the time of open cytoreductive surgery for ovarian cancer
    Miscellaneous

    Finch, L.; Muhammad, D. A.; Chi, D. S.
    Gynecologic Oncology Reports (2024)

    Fulltext@MSK | Save
  • A phase I study of acapatamab, a half-life extended, PSMA-targeting bispecific T-cell engager for metastatic castration-resistant prostate cancer
    Journal Article

    Dorff, T.; Horvath, L. G.; Autio, K.; Bernard-Tessier, A.; Rettig, M. B.; Machiels, J. P.; Bilen, M. A.; Lolkema, M. P.; Adra, N.; Rottey, S.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • Application of deep learning on mammographies to discriminate between low and high-risk DCIS for patient participation in active surveillance trials
    Journal Article

    Alaeikhanehshir, S.; Voets, M. M.; van Duijnhoven, F. H.; lips, E. H.; Groen, E. J.; van Oirsouw, M. C. J.; Hwang, S. E.; Lo, J. Y.; Wesseling, J.; Mann, R. M.; more...
    Cancer Imaging (2024)

    Fulltext@MSK | Save
  • Magnetic resonance imaging-targeted prostate biopsy changed everything (so everything has to change)
    Editorial

    Vickers, A.
    BJU International (2024)

    Fulltext@MSK | Save